TrialClinical pharmacokinetics2024

P2X3 Receptor Antagonist Eliapixant in Phase I Clinical Trials: Safety and Inter-ethnic Comparison of Pharmacokinetics in Healthy Chinese and Japanese Participants.

Xuening Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.